By JNi.Media
BioTheryX recently bought the rights to this promising drug from HU’s technology transfer company Yissum.
By JNi.Media
Small and medium sized HDL particles were more closely associated than HDL-C with protection against coronary atherosclerosis in a Jerusalem study.